Little Rock, Ark.– Research Solutions, LLC, a Phase II-IV clinical trials management organization, has acquired Arkansas Research Medical Testing, Inc., a Phase I-IIa clinical trials research testing center. Both firms are located in Little Rock. The transaction was financed through a combination of bank debt and equity capital provided by Research Solutions’ existing investors and a new outside investor.

Mr. Jennings Osborne, the well-known founder of Arkansas Research Medical Testing, Inc., will continue as a development consultant. Mr. David J. Jones, President and CEO of Research Solutions, LLC, has been appointed President and CEO of Arkansas Research as well.

Arkansas Research, founded in 1968, is considered one of the country’s largest Phase I facilities, having conducted clinical trials for all the major pharmaceutical companies. The firm conducts clinical trials in its overnight private and semi-private, extended stay facility. The Arkansas Research complex is capable of housing 200 patients for single or concurrent trials. The majority of Research Solutions' Phase II-IV clinical trials are conducted on an outpatient basis.

“Arkansas Research’s extensive database and fast recruiting skills makes us one of the most reliable choices in the industry. We have been chosen to provide clinical trial services time and time again because of our solid access to special populations,” said Mr. Osborne, continuing “Our current volunteer database includes; healthy male/female, surgically sterile/ postmenopausal, osteo/rheumatoid arthritis, asthmatic, HIV positive, volunteers with hypertension, diabetics, as well as healthy geriatric/pediatric volunteers. Screening and outpatient clinics are located in the same building but separated from in-patient areas.”

“Our association with Arkansas Research provides our pharmaceutical clients with accelerated clinical trial data acquisition in all four phases of the clinical trial process,” stated David J. Jones, now Chief Executive Officer of both Research Solutions and Arkansas Research. “Our mission is to ‘Advance the Cure’ by assisting the pharmaceutical and biotechnology industries in bringing new and important drug product discoveries to market.”

Mr. Jones continued, “Both Arkansas Research and Research Solutions will benefit from combining our management and clinical trials expertise,” “Research Solutions’ centralized management structure is based on an affiliated, site-staffed model.”

This summer, Research Solutions is celebrating its fifth year in business.

Research Solutions partners with nearly 150 community-based physicians, providing direct support services including overall study management, regulatory, budgets, patient recruitment, quality assurance, research staff, study tracking and reporting. Patient services include centralized patient recruitment media campaigns and a central call center.

Research Solutions, LLC, a national leader in clinical trials management, conducts clinical research studies at over 100 clinical sites in Alabama, Arkansas, Indiana, Iowa, Kentucky, Louisiana, New Mexico, New York, Ohio, Oklahoma, Tennessee and Texas. Corporate offices are located in Little Rock, Arkansas. Complete information is available on the company’s web site: http://www.researchsolutionscorp.com

###